Fundraising Fox
/People
Sign in

Kasper Roet

Founder

Director at EnClear Therapies · Founder at Quralis

Greater Boston

FoundedQuralis

Find your path to Kasper

186 people in our graph share verified history with Kasper — schools, employers, funds. One of them is your warm intro.

María RennerunlockedKasper: together at Netherlands Institute for Neuroscience (2011–2012)
×2Kasper: together at Harvard Stem Cell Institute
×3Kasper: together at Thrivebio
×5Kasper: together at EnClear Therapies

About

Kasper Roet is the founder and CEO of QurAlis, a company focused on developing therapies for Amyotrophic Lateral Sclerosis (ALS). The company uses patient-derived stem cell technologies to study disease mechanisms in motor neurons and applies a precision medicine approach to identify potential treatments.

Director at EnClear Therapies

Intro paths

→

In turn, Kasper can intro founders to EnClear Therapies's investors below.

EnClear Therapies's investors · 7

20/20 HealthCare Partners LLCAuburndale · since 2024Amgen VenturesThousand Oaks · $1M – $3M checks · since 2024Dolby Family VenturesSan Francisco · since 2024Flucas VenturesJupiter · $100K – $5M checks · since 2024Founders FundSan Francisco · $500K – $5M checks · since 2024Tachyon VenturesLos Angeles · since 2024VU Venture PartnersSan Francisco · $200K – $1M checks · since 2024

Co-founders at EnClear Therapies

ADAnthony DePasqua
Anthony DePasquaExecutive Officer, Director

Founder at Quralis

Intro paths

→

In turn, Kasper can intro founders to Quralis's investors below.

Quralis's investors · 15

Amgen VenturesThousand Oaks · $1M – $3M checks · since 2023Dementia Discovery FundLondon · since 2023Diamond Edge VenturesSan Francisco · since 2018Dolby Family VenturesSan Francisco · since 2023Droia VenturesLuxembourg · $540K checks · since 2025EQT Life SciencesLuxembourg · $11M – $66M checks · since 2023InkefAmsterdam · since 2023MC Healthcare VenturesCambridgeMission Bay CapitalSan Francisco · since 2023Mission BiocapitalSan Francisco · $500K checks · since 2025Mitsui Global InvestmentMenlo Park · $500K – $10M checks · since 2023Polaris PartnersBoston · $500K – $5M checks · since 2025Sanofi VenturesCambridge · $5M checks · since 2023SV Health InvestorsBoston · $1M – $20M checksSynconaLondon · since 2022

Co-founders at Quralis

KEKevin Eggan
Kevin EgganCo-founder
R
RoetCo-founder
W
WoolfCo-founder

Experience

  1. QurAlisFounder and CEO of QurAliscurrent2017 — presentCambridge, US
  2. EnClear TherapiesBoard member and Scientific Advisory Board membercurrent2018 — presentMassachusetts, United States
  3. Harvard Medical School/ Boston Children's Hospital/ Harvard UniversityFellowcurrent2014 — presentGreater Boston
  4. Thrive Bioscience, Inc.Product Development Advisory Panel membercurrent2016 — present
  5. Harvard Stem Cell InstituteProject Alliance Manager2016 — 20177 Divinity Avenue, Cambridge
  6. Kasper Roet AdviesBusiness Owner2012 — 2014Amsterdam
  7. CrucellScientist and Team leader Molecular Bioassays and Functional technical integrator2012 — 2013Leiden
  8. The Netherlands Brain BankAutopsy team coordinator2008 — 2013
  9. Netherlands Institute for NeurosciencePhD project in Senternovem consortium project2006 — 2012
  10. University California San DiegoStudent project at the Center for Neural Repair2006
  11. Alex BeleggersbankService desk2005
  12. Institute for NeuroscienceStudent project at Dept. Neuroregeneration2004 — 2005
  13. NetfaseIT-entrepeneur2002 — 2005
  14. Nationale Postcode LoterijSupervisor telemarketing2001 — 2004
  15. Netherlands Cancer InstituteStudent project at Dept. Molecular Carcinogenesis2003

Skills & more

Molecular Biology26Neuroscience39Molecular Cloning2Product Development2Research Project Management3Systems AnalysisSales Presentations2Training Skills1People Management4Regenerative MedicineDrug Delivery1Fluorescence Microscopy1
+9 moreImmunohistochemistryImmunocytochemistryAnimal ModelsHigh Throughput ScreeningCandidate SelectionCell CultureCell Based AssaysLife SciencesHealthcare

Languages Dutch

  • PhD in Molecular Biology — United Latino Students Association

From Kasper's professional profile.

Frequently asked questions

Who is Kasper Roet?
Kasper Roet is the founder and CEO of QurAlis, a company focused on developing therapies for Amyotrophic Lateral Sclerosis (ALS). The company uses patient-derived stem cell technologies to study disease mechanisms in motor neurons and applies a precision medicine approach to identify potential treatments.
Where does Kasper Roet work?
Kasper Roet is Founder of Quralis.
What companies did Kasper Roet found?
Kasper Roet founded Quralis.
Where did Kasper Roet go to school?
Kasper Roet studied at Graduate School Neurosciences Amsterdam and Rotterdam (PhD, Neuroscience); University of Amsterdam (MSc, Biomedical sciences focused on neuroscience).

Founder mafias

Same school

Shared employers

Also worked at Netherlands Institute for Neuroscience1

María RennerGeneral Partner at GRIDX